AAPL313.39+2.73 (+0.88%) ▲|ABBV252.74-1.91 (-0.75%) ▼|ABT95.18-0.66 (-0.69%) ▼|ACN137.19-4.95 (-3.48%) ▼|ADBE220.94-0.60 (-0.27%) ▼|AMAT570.50+16.00 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.04-0.21 (-0.13%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.39-13.19 (-3.77%) ▼|BA224.95-6.73 (-2.90%) ▼|BAC58.30-1.56 (-2.61%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.34-19.09 (-1.89%) ▼|BMY57.54-0.43 (-0.74%) ▼|BNY150.14-2.77 (-1.81%) ▼|BRK-B494.79-9.21 (-1.83%) ▼|C137.39-3.38 (-2.40%) ▼|CAT948.08+7.96 (+0.85%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.95-10.94 (-5.39%) ▼|COP110.72+2.28 (+2.10%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.58-2.94 (-1.73%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.47+0.14 (+0.13%) ▲|CVX175.97+1.96 (+1.13%) ▲|DE596.74-6.87 (-1.14%) ▼|DHR190.77-3.42 (-1.76%) ▼|DIS96.70-0.78 (-0.80%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.48-1.43 (-1.04%) ▼|FDX309.76-3.12 (-1.00%) ▼|GD374.31-0.33 (-0.09%) ▼|GE356.03-10.95 (-2.98%) ▼|GEV1,070.99-6.09 (-0.57%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.24+0.21 (+0.28%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.64-13.34 (-1.28%) ▼|HD336.21-9.00 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM302.05-4.08 (-1.33%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.40-3.84 (-1.44%) ▼|JPM330.62-8.60 (-2.54%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.83-19.73 (-1.60%) ▼|LMT527.96-7.42 (-1.39%) ▼|LOW212.85-8.05 (-3.64%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.86-11.76 (-2.21%) ▼|MCD278.25-3.96 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.01-1.82 (-2.17%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.70-3.31 (-2.09%) ▼|MO72.81-0.15 (-0.21%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.07-3.97 (-1.79%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.44-1.03 (-1.16%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.89-0.32 (-0.74%) ▼|NOW107.78-2.95 (-2.66%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.49-1.11 (-0.78%) ▼|PEP142.51-2.47 (-1.70%) ▼|PFE24.05-0.02 (-0.08%) ▼|PG148.40-4.35 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.07-0.72 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.91-5.94 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.70-0.23 (-0.23%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.09-8.10 (-3.57%) ▼|T21.12+0.03 (+0.14%) ▲|TMO510.13-6.49 (-1.26%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA394.06-8.84 (-2.19%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.60-0.73 (-0.98%) ▼|UNH425.60-2.59 (-0.60%) ▼|UNP280.94-2.18 (-0.77%) ▼|UPS109.94-2.02 (-1.80%) ▼|USB61.00-1.89 (-3.01%) ▼|V347.53-4.67 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.56-1.62 (-1.86%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM141.13-0.56 (-0.40%) ▼|AAPL313.39+2.73 (+0.88%) ▲|ABBV252.74-1.91 (-0.75%) ▼|ABT95.18-0.66 (-0.69%) ▼|ACN137.19-4.95 (-3.48%) ▼|ADBE220.94-0.60 (-0.27%) ▼|AMAT570.50+16.00 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.04-0.21 (-0.13%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.39-13.19 (-3.77%) ▼|BA224.95-6.73 (-2.90%) ▼|BAC58.30-1.56 (-2.61%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.34-19.09 (-1.89%) ▼|BMY57.54-0.43 (-0.74%) ▼|BNY150.14-2.77 (-1.81%) ▼|BRK-B494.79-9.21 (-1.83%) ▼|C137.39-3.38 (-2.40%) ▼|CAT948.08+7.96 (+0.85%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.95-10.94 (-5.39%) ▼|COP110.72+2.28 (+2.10%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.58-2.94 (-1.73%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.47+0.14 (+0.13%) ▲|CVX175.97+1.96 (+1.13%) ▲|DE596.74-6.87 (-1.14%) ▼|DHR190.77-3.42 (-1.76%) ▼|DIS96.70-0.78 (-0.80%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.48-1.43 (-1.04%) ▼|FDX309.76-3.12 (-1.00%) ▼|GD374.31-0.33 (-0.09%) ▼|GE356.03-10.95 (-2.98%) ▼|GEV1,070.99-6.09 (-0.57%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.24+0.21 (+0.28%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.64-13.34 (-1.28%) ▼|HD336.21-9.00 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM302.05-4.08 (-1.33%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.40-3.84 (-1.44%) ▼|JPM330.62-8.60 (-2.54%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.83-19.73 (-1.60%) ▼|LMT527.96-7.42 (-1.39%) ▼|LOW212.85-8.05 (-3.64%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.86-11.76 (-2.21%) ▼|MCD278.25-3.96 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.01-1.82 (-2.17%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.70-3.31 (-2.09%) ▼|MO72.81-0.15 (-0.21%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.07-3.97 (-1.79%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.44-1.03 (-1.16%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.89-0.32 (-0.74%) ▼|NOW107.78-2.95 (-2.66%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.49-1.11 (-0.78%) ▼|PEP142.51-2.47 (-1.70%) ▼|PFE24.05-0.02 (-0.08%) ▼|PG148.40-4.35 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.07-0.72 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.91-5.94 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.70-0.23 (-0.23%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.09-8.10 (-3.57%) ▼|T21.12+0.03 (+0.14%) ▲|TMO510.13-6.49 (-1.26%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA394.06-8.84 (-2.19%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.60-0.73 (-0.98%) ▼|UNH425.60-2.59 (-0.60%) ▼|UNP280.94-2.18 (-0.77%) ▼|UPS109.94-2.02 (-1.80%) ▼|USB61.00-1.89 (-3.01%) ▼|V347.53-4.67 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.56-1.62 (-1.86%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM141.13-0.56 (-0.40%) ▼|
30.4 C
New York
Wednesday, July 8, 2026

Tag: program

newssourceFORcompanyinformationcontent1releasesmarket

Seventh Presale Phase: Bitcoin Solaris Nears Public Launch with 10,000 TPS and 21M Supply Cap

TALLINN, Estonia, June 15, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a next-generation blockchain built for speed, accessibility, and long-term sustainability, has officially entered the seventh phase of its token presale, with the public launch now just weeks away. With over $4.5 million already raised and more than 11,500 participants onboard, momentum is surging.

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for...

Media Release

COPENHAGEN, Denmark; June 15, 2025

KIWI design Celebrates One Million Head Straps Sold, Redefines VR Comfort with Series Made for Meta Products

LOS ANGELES, June 15, 2025 /PRNewswire/ -- KIWI design, a pioneer in VR accessories, announced surpassing one million head strap sales, delivering enhanced comfort...

Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of GPRC5D and BCMA Data signal...

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ (delandistrogene moxeparvovec), for non-ambulatory Duchenne muscular dystrophy (DMD) patients, irrespective of age, in both clinical and commercial settings. In the commercial setting, non-ambulatory patients should no longer receive Elevidys. In the clinical trial setting, enrolment and dosing of non-ambulatory patients will be immediately paused until additional risk mitigation measures (e.g. immune modulatory treatment) are implemented in the study protocol. Health authorities, investigators and physicians are being informed so that patient care can be quickly adjusted.

FOX NEWS CHANNEL’S BRET BAIER LANDS FIRST INTERVIEW WITH ISRAELI PRIME MINISTER BENJAMIN NETANYAHU SINCE ISRAEL’S STRIKES ON IRAN ON SUNDAY, JUNE 15TH

NEW YORK, June 14, 2025 /PRNewswire/ -- FOX News Channel's Bret Baier will present a worldwide exclusive live interview with Israeli Prime Minister Bibi Netanyahu on...

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 52 weeks in the Company’s Phase 2 clinical trial in chronic spontaneous urticaria (CSU). Angioedema, characterized by swelling of the deeper dermal layers of the skin and mucous membranes, is a painful, debilitating symptom of CSU that has significant impact on quality of life. It commonly affects the face (lips and eyelids), hands, feet, and genitalia but can also involve the tongue, uvula, soft palate, and pharynx1.

PFMCrypto’s “1-Day Mining Contract” Sales Surge 76% – $1 Million Giveaway Ignites Community Buzz

As PFMCrypto’s AI-driven mining model gains momentum, the platform celebrates a major milestone with a global bonus campaign for new users 
As PFMCrypto’s AI-driven mining model gains momentum, the platform celebrates a major milestone with a global bonus campaign for new users

UPDATE — Ready Capital Corporation Declares Second Quarter 2025 Dividends

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE:RC) (the “Company”) announced that its Board of Directors declared a quarterly cash dividend of $0.125 per share of common stock and Operating Partnership unit for the quarter ended June 30, 2025. This dividend is payable on July 31, 2025, to shareholders of record as of the close of business on June 30, 2025.

The Joe Spot Launches Online Coffee Store Offering Artisan Blends, Single Origin Beans, and Fast Coffee Delivery Across the USA

Marina Del Rey, California-based brand introduces specialty coffee online with premium beans, fast shipping, and subscription options 
Marina Del Rey, California-based brand introduces specialty coffee online with premium beans, fast shipping, and subscription options

Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Investors in Abacus Global Management, Inc. (NASDAQ: ABL) experienced another substantial decline in share price today following the release of a second scathing report from Morpheus Research. Morpheus, a collective of financial analysts known for their focus on uncovering alleged fraud and corporate malfeasance, has now published two critical analyses of Abacus within a week, alleging the life settlements company has engaged in improper accounting.

THE INTERNATIONAL SCHOOL OF SAN FRANCISCO APPOINTS ERIC THUAU AS ITS NEXT HEAD OF SCHOOL

SAN FRANCISCO, Calif., June 13, 2025 /PRNewswire/ -- Following an extensive search, The International School of San Francisco is delighted to announce the appointment...

Aerial, an Argosy Portfolio Company, Acquires Hazard Protection Systems

WAYNE, Pa., June 13, 2025 /PRNewswire/ -- Aerial Machine & Tool, ("Aerial"), a portfolio company of Argosy Private Equity has completed the acquisition of Hazard...

AHOMO Fund to Acquire 3,500 Homes Across 42 States Using CloseAbility Platform

Only 105 agent spots available—9 already gone. Apply now to secure your territory and represent the AHOMO Fund. Licensed agent-investors and investors working with agents...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgram

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers